These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 7692048)

  • 61. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of CCK-JMV-180 on food intake in rats and mice.
    Asin KE; Bednarz L
    Pharmacol Biochem Behav; 1992 Jun; 42(2):291-5. PubMed ID: 1631182
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
    Heidbreder C; Roques BP; De Witte P
    Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.
    Holladay MW; Bennett MJ; Tufano MD; Lin CW; Asin KE; Witte DG; Miller TR; Bianchi BR; Nikkel AL; Bednarz L
    J Med Chem; 1992 Aug; 35(16):2919-28. PubMed ID: 1501220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence for cholecystokinin receptor subtype in endocrine pancreas.
    Verspohl EJ; Hafner B; He X; Knittel JJ
    Peptides; 1994; 15(8):1353-60. PubMed ID: 7535422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.
    Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J
    J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.
    Horwell DC; Beeby A; Clark CR; Hughes J
    J Med Chem; 1987 Apr; 30(4):729-32. PubMed ID: 3560164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a beta-alanine.
    Rodriguez M; Rolland M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1989 Nov; 34(5):394-404. PubMed ID: 2482263
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake.
    Gourch A; Orosco M; Rodriguez M; Martinez J; Jacquot C; Cohen Y
    Neuropeptides; 1990 Dec; 17(4):187-91. PubMed ID: 2093151
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
    Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K; Gigoux V; Escrieut C; Maigret B; Martinez J; Moroder L; Fréhel D; Gully D; Vaysse N; Fourmy D
    J Biol Chem; 1997 Jan; 272(5):2920-6. PubMed ID: 9006937
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV; Kolodziej SA; Nock B; Bernad N; Martinez J; Marshall GR
    Biopolymers; 1995 Oct; 36(4):439-52. PubMed ID: 7578939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.
    Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J
    Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
    Sarri E; Ramos B; Salido GM; Claro E
    Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
    Durieux C; Ruiz-Gayo M; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion.
    Tsunoda Y; Owyang C
    Am J Physiol; 1995 Sep; 269(3 Pt 1):G435-44. PubMed ID: 7573455
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
    Tsunoda Y; Owyang C
    Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.